Given the prominent role of IL-1 signaling in inflammation and metabolic diseases, we investigated the relevance of the hepatocyte-specific IL-1 receptor type 1 knockout in metabolic dysfunction–associated steatohepatitis–related noncirrhotic HCC. Here, IL1B is linked to metabolic disease.